Somatic variant classification is the algorithmic process of labeling genetic alterations identified in a tumor sample as somatic mutations, germline variants, or sequencing artifacts. It operates on a matched tumor-normal pair to subtract the patient's inherited genetic background, isolating mutations acquired during oncogenesis. The core challenge lies in modeling variant allele fractions (VAF) and read-level error profiles to differentiate low-frequency true mutations from technical noise.
Glossary
Somatic Variant Classification

What is Somatic Variant Classification?
The computational task of distinguishing acquired mutations present only in tumor cells from inherited germline polymorphisms and sequencing artifacts using a matched tumor-normal sample pair.
Modern classifiers integrate deep learning with Bayesian statistical frameworks, analyzing features like strand bias, base quality, and local sequence context. By assigning probabilistic scores to each variant, these systems enable clinical labs to prioritize driver mutations for targeted therapy while filtering out benign polymorphisms and homopolymer indel errors that plague next-generation sequencing data.
Core Discriminative Features
The computational logic that separates true tumor-specific mutations from inherited polymorphisms and technical noise using a matched tumor-normal pair.
Tumor-Normal Subtraction Logic
The foundational principle of somatic calling relies on a matched tumor-normal pair from the same individual. By comparing the Variant Allele Fraction (VAF) and genotype likelihoods at every locus, the algorithm subtracts the germline baseline. A variant present in the tumor but absent in the normal sample is classified as a somatic mutation. This direct subtraction eliminates the need for population-level frequency databases to filter private germline variants, though it requires precise read-backed phasing to avoid misclassifying low-purity tumor signals as heterozygous germline events.
Variant Allele Fraction (VAF) Modeling
Somatic classification hinges on the Variant Allele Fraction—the ratio of reads supporting the alternate allele to total depth. Unlike the fixed 50% or 100% ratios expected in germline heterozygosity or homozygosity, somatic VAFs are continuous and influenced by tumor purity and clonal heterogeneity. Advanced callers build statistical models of expected VAF distributions to distinguish true subclonal mutations from strand bias artifacts or homopolymer indel errors. A low VAF in the normal sample often indicates a sequencing error or circulating tumor DNA contamination rather than a true germline event.
Artifact Source Discrimination
The primary challenge is rejecting false positives that mimic somatic mutations. Key discriminative features include:
- Strand Bias: Variant alleles concentrated on a single DNA strand indicate oxidative damage during library preparation.
- Mapping Quality: Low mapping quality scores at the locus suggest mismapped reads or paralogous sequences.
- Base Quality Dropoff: Systematic reduction in base quality scores near the variant position flags sequencing cycle errors.
- Homopolymer Length: Indels in repetitive contexts are weighted against known polymerase slippage error rates. Classifiers integrate these features to assign a somatic probability score.
Joint Genotyping vs. Single-Sample Calling
While single-sample somatic callers operate on one tumor-normal pair, joint genotyping across a cohort of tumors can rescue low-VAF mutations missed in individual samples. By sharing statistical evidence across multiple samples, the model learns locus-specific error profiles and identifies recurrent hotspot mutations. However, this approach risks cross-sample contamination and requires strict batch effect correction. Modern deep learning callers like DeepVariant treat each sample independently but leverage population-informed priors during training to improve rare variant sensitivity.
Local Reassembly for Complex Events
Simple alignment-based subtraction fails at loci with complex somatic events like multi-nucleotide variants (MNVs) or small insertions adjacent to deletions. Local reassembly performs targeted de novo assembly of reads mapping to a candidate region, constructing a De Bruijn graph to resolve the true haplotypes. This approach distinguishes a single complex somatic event from two adjacent simple germline variants, preventing incorrect classification. The reassembled contigs are realigned to the reference to generate a precise CIGAR string describing the somatic edit.
Somatic-Germline-Zygosity Classification
Modern classifiers output a three-way probability distribution: somatic, germline, or loss of heterozygosity (LOH). LOH events occur when the tumor loses one parental allele, converting a heterozygous germline site to an apparently homozygous somatic state. Distinguishing LOH from a true somatic mutation requires analyzing the B-allele frequency across a haplotype block and integrating copy number variation calls. This multi-class framework prevents the misclassification of copy-neutral LOH as a somatic point mutation.
Frequently Asked Questions
Answers to the most common technical questions about distinguishing true tumor-specific mutations from inherited polymorphisms and sequencing artifacts using matched tumor-normal analysis.
Somatic variant classification is the computational process of distinguishing acquired mutations present only in tumor cells from inherited germline polymorphisms and technical sequencing artifacts. The process requires a matched tumor-normal pairing strategy, where both cancerous tissue and healthy tissue from the same individual are sequenced simultaneously. The classifier operates by comparing Variant Allele Fraction (VAF) ratios between the two samples—a true somatic mutation will show a significantly higher VAF in the tumor sample relative to the matched normal, while germline variants maintain consistent allele fractions across both tissues. Modern deep learning classifiers, such as DeepVariant adapted for somatic calling, encode aligned reads into pileup images and apply convolutional neural networks to learn complex features including strand bias patterns, mapping quality distributions, and base quality profiles that distinguish true biology from systematic errors like homopolymer indel errors and strand bias artifacts.
Enabling Efficiency, Speed & Accuracy
Intelligent Analysis, Decision & Execution
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Talk to Us
Search across company data
Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.
Useful when people spend too long searching or get different answers from different systems.

Automate internal workflows
Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.
Useful when repetitive work moves across multiple tools and teams.

Add AI to products and internal tools
Build assistants, guided actions, or decision support into the software your team or customers already use.
Useful when AI needs to be part of the product, not a separate tool.
Related Terms
Master the computational ecosystem surrounding the identification of true tumor-specific mutations. These concepts are essential for distinguishing driver events from germline noise and technical artifacts.
Tumor-Normal Pairing
The foundational experimental design for somatic analysis. By sequencing both cancerous tissue and healthy tissue (often blood or adjacent normal) from the same individual, algorithms can computationally subtract inherited germline variants to isolate acquired somatic mutations. Without a matched normal, population frequency databases must be used, increasing false positive rates for rare population-specific polymorphisms.
Variant Allele Fraction (VAF)
A critical quantitative metric defined as the proportion of sequencing reads supporting a variant allele relative to the total read depth at that locus. In somatic calling, VAF is used to:
- Distinguish heterozygous germline variants (~50% VAF) from subclonal somatic mutations (low VAF).
- Infer tumor purity and clonal architecture.
- Identify potential sequencing artifacts, which often exhibit very low VAF and strand bias.
Strand Bias Artifact
A systematic sequencing error where a variant allele is observed predominantly on reads from one DNA strand (forward or reverse). True biological mutations are expected to be randomly distributed across both strands. Fisher's Exact Test or Wilcoxon rank-sum tests are commonly used to quantify strand bias. A significant skew indicates a technical artifact from oxidative damage during library preparation or sequencing chemistry errors.
Germline Variant Calling
The parallel process of identifying inherited genetic variations present in all cells. While somatic callers look for differences between tumor and normal, germline callers analyze a single sample against a reference genome using diploid genotype likelihoods. Accurate germline filtering is the first step in somatic classification; any variant with a high population frequency or a clear heterozygous genotype in the matched normal must be subtracted.
Variant Quality Score Recalibration (VQSR)
A machine learning technique using a Gaussian Mixture Model to assign a well-calibrated error probability to each variant call. VQSR trains on high-confidence truth sets (like Genome in a Bottle) and multiple annotation features to separate true variants from artifacts. The output is a VQSLOD score—the log odds of being a true variant—which is far more reliable than raw quality scores for filtering somatic candidates.
False Discovery Rate Control
Statistical procedures applied to variant calling results to limit the expected proportion of false positives. The Benjamini-Hochberg procedure is commonly used to adjust p-values for multiple testing across millions of genomic loci. In somatic analysis, controlling the FDR is critical because the prior probability of a true somatic mutation is extremely low, and the number of tested positions is vast.

About the author
Prasad Kumkar
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
Partnered with leading AI, data, and software stack.
How We Work
Custom AI workflows for your Business
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
01
Review the use case
We understand the task, the users, and where AI can actually help.
Read more02
Pick the right approach
We define what needs search, automation, or product integration.
Read more03
Build the first useful version
We implement the part that proves the value first.
Read more04
Improve from there
We add the checks and visibility needed to keep it useful.
Read moreThe first call is a practical review of your use case and the right next step.
Talk to Us